Nor Azura Azmi

Nor Azura Azmi

Auto-generated profile, based on publicly available information

Nor Azura Azmi

Center for Rehabilitation and Special Needs (ICaRehab) and Physiotherapy Programme, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SASuriah Ahmad
Suriah Ahmad
NANor Azura Azmi
Nor Azura Azmi
NANur Ayub Md Ali
Nur Ayub Md Ali
AKAli Katijjahbe
Ali Katijjahbe
ICIan Chik
Ian Chik
AWAdzim Poh Yuen Wen
Adzim Poh Yuen Wen
Background: Prehabilitation programmes for major abdominal surgery enhance patients’ condition preoperative and promote recovery by building surgical resilience. However, the precise protocol of prehabilitation pertaining to the prescription of exercise training remains undefined. This paper describes the protocol of the study that aims to evaluate the effectiveness of high-intensity interval training (HIIT) compared to moderate intensity continuous training (MICT) among patients undergoing major abdominal surgery. Methods: This is pragmatic double-blind randomized controlled trial, with parallel group, concealed allocation and blinding of patients and assessors. A total of 70 participants will be recruited from the surgery and anaesthetic clinic at the Hospital Canselor Tuanku Muhriz. Participants will be randomly allocated 1:1 to either receive HIIT (intervention group) or MICT (control group) with 35 participants in each group. Both groups will receive body conditioning and respiratory muscle strength exercises of HIIT for participants in the intervention group, while MICT for the control group. This will be one-hour therapist-supervised intervention sessions for at least 4 weeks duration with 1–3 sessions per week before the surgery. The patient will be assessed at baseline, before the operation at 4-week following intervention, prior to discharge, at 4 weeks and 3 months postoperatively. The primary outcome measures are 6-minute walking test and maximum inspiratory pressure. The secondary outcomes will be multidomain recovery of physical performances, psychological, and quality of life. All data will be analyzed using descriptive and inferential statistics, particularly Mixed Model ANOVA. The statistical significance value will be set at p < 0.05. The trial is currently recruiting participants. Conclusions: The findings of this research will inform guidelines on optimal exercise dosage and intensity for prehabilitation in patients undergoing major abdominal surgery. Protocol registration: The protocol of this study is registered in the Australia New Zealand Clinical Trial Registry with registration number ACTRN12625000023459.

13 September 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ESEnas Hussien Shaltaf
Enas Hussien Shaltaf
SMSumaiyah Bent Mat
Sumaiyah Bent Mat
NANor Azura Azmi
Nor Azura Azmi
AAAlia A. Alghwiri
Alia A. Alghwiri
DSDevinder Kaur Ajit Singh
Devinder Kaur Ajit Singh
Long COVID is associated with persistent fatigue, dyspnea, and reduced functional capacity, yet access to centre-based pulmonary rehabilitation remains limited, particularly in low- and middle-income settings. This study aimed to develop a consensus-based, evidence-informed home-based pulmonary rehabilitation (HBPR) programme for individuals with Long COVID in Jordan through an expert consensus survey informed by qualitative item generation. The programme development process involved a qualitative item-generation phase followed by a quantitative consensus survey with 15 experts, including physiotherapists and rehabilitation physicians with expertise in pulmonary rehabilitation and Long COVID management. The qualitative item-generation phase was informed by findings from a prior systematic review and meta-analysis, with qualitative responses analyzed thematically to generate preliminary programme components. In the subsequent consensus survey, experts rated the importance and feasibility of each component using a 5-point Likert scale, with consensus defined as ≥ 70% agreement and a median score of ≥ 4. Of 97 statements evaluated, 90 (92.8%) achieved consensus. The final HBPR programme included recommendations on programme structure, safety, exercise prescription, patient education, pacing, symptom-guided progression, screening for post-exertional malaise, and low-technology delivery, while components requiring intensive supervision or advanced technology were considered less feasible. This consensus-based, evidence-informed HBPR programme provides a structured framework for home-based rehabilitation in individuals with Long COVID, particularly in resource-limited settings, and warrants further evaluation of its feasibility, acceptability, and clinical effectiveness.

21 March 2026 in Interdisciplinary CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
NANur Ayub Mohd Ali
Nur Ayub Mohd Ali
MKMohd Ali Katijjahbe
Mohd Ali Katijjahbe
DEDoa El-Ansary
Doa El-Ansary
NANor Azura Azmi
Nor Azura Azmi
TCTze Huat Chong
Tze Huat Chong
MMMohd Rizal Abdul Manaf
Mohd Rizal Abdul Manaf
This study reported the preliminary analysis of a Phase II prospective, double‑blind, randomized controlled trial that tested the Early Supervised Incremental Resistance Training (ESpIRiT) intervention following median sternotomy, and explored its effects on upper limb function and patient‑reported pain at four weeks and three months. Primary outcomes were safety(defined by sternal wound complications); feasibility(assessed by recruitment and adherence; and upper limb function measured by the Unsupported Upper Limb Exercise Test(UULEX). Secondary outcomes included the Functional Difficulty Questionnaire Shortened Version(FDQ‑s) and pain using the Numeric Rating Scale(NSR). Assessments occurred at baseline, discharge, four weeks, and three months postoperatively. Fifty‑five participants were recruited(ESpIRiT n = 27; standard care n = 28). No sternal complications occurred(RR 0.963, 95% CI 0.057–16.21). Adherence was 80%, with no dropouts. Between‑group differences in UULEX were not significant at four weeks(MD 1.49, 95% CI –4.62 to 7.16) or three months(MD 1.19, 95% CI –5.58 to 7.79). No significant differences were found for FDQ‑s or NSR. Within‑group analyses showed significant improvements in UULEX, FDQ‑s, and NSR over time. ESpIRiT was safe, feasible, and well‑accepted in the acute inpatient setting, with strong recruitment, adherence, and no adverse events. Trial registration: ISRCTN 17842822, registered 11 March 2020.